. tusk made his remarks about the u.s. president's reliability before he chaired a meeting in bulgaria of the 28 leaders whose countries make up the world's biggest trading bloc...
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust...